Company Overview
Snapshot
Founded in January 2004, Motorika operated with 11–50 employees, developing robotic rehabilitation solutions. The company ceased operations in December 2022.
Business overview
Motorika specializes in developing robotic rehabilitation solutions designed for patients recovering from various neurological and orthopedic conditions, including stroke, traumatic brain injury, and spinal cord injury. The company's core technology leverages principles of neuroplasticity, repetitive motion, and biofeedback through platforms like ReoGo for upper limb therapy and Optimal-G Pro for gait rehabilitation. Motorika's products are commercially available in 33 countries, serving hospitals and clinics within the Health Tech & Life Sciences sector.
Strategic signal
In January 2019, Motorika unveiled its Optimal-G Pro Robotic Gait Rehab System, a significant product launch that expanded its portfolio of rehabilitation solutions. This introduction demonstrated the company's continued innovation in assistive devices and its commitment to advancing personalized robotic platforms for gait rehabilitation, signaling a focus on enhancing patient recovery outcomes.
Company Intelligence Q&A
- What is Motorika's primary focus?
- Motorika focuses on developing robotic rehabilitation solutions for patients with neurological and orthopedic conditions, such as stroke, traumatic brain injury, and spinal cord injury.
- When was Motorika founded?
- Motorika was founded in January 2004.
- What are Motorika's key products?
- Motorika's key products include the ReoGo for upper limb therapy and the Optimal-G Pro for gait rehabilitation, both designed to assist in patient therapy sessions.
- In which markets are Motorika's products available?
- Motorika's products are commercially available in 33 countries worldwide, including Europe, the U.S., and China.
- What was a notable product launch for Motorika?
- In January 2019, Motorika unveiled its Optimal-G Pro Robotic Gait Rehab System, expanding its offerings in robotic rehabilitation.